Review: The role of insulin resistance in nonalcoholic fatty liver disease.
about
Nonalcoholic Fatty liver disease and risk of diabetes and cardiovascular disease: what is important for primary care physicians?Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver diseaseDevelopment of nonalcoholic hepatopathy: contributions of oxidative stress and advanced glycation end productsMacrophage migration inhibitory factor deficiency ameliorates high-fat diet induced insulin resistance in mice with reduced adipose inflammation and hepatic steatosisThe effects of low carbohydrate diets on liver function tests in nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trialsAltered glucose homeostasis and hepatic function in obese mice deficient for both kinin receptor genesValue of MRI and MRS fat measurements to complement conventional screening methods for childhood obesity.Impact of resistant starch on body fat patterning and central appetite regulation.Fatty liver disease in children: eat now pay later.Insulin increases ceramide synthesis in skeletal muscleAssociation of low muscle mass and combined low muscle mass and visceral obesity with low cardiorespiratory fitness.Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss dietLycium barbarum polysaccharides therapeutically improve hepatic functions in non-alcoholic steatohepatitis rats and cellular steatosis modelMajor Components of Metabolic Parameters and Nutritional Intakes in Different Genotypes of Adiponectin +276 G>T Gene Polymorphism in Non-Diabetes and Non-Alcoholic Iranian Fatty Liver Patients.Proteomic and genomic studies of non-alcoholic fatty liver disease--clues in the pathogenesisNonalcoholic fatty liver disease and polycystic ovary syndrome.Molecular pathways in non-alcoholic fatty liver disease.Predicting hepatic steatosis in a racially and ethnically diverse cohort of adolescent girls.Management of nonalcoholic fatty liver disease: an evidence-based clinical practice review.Transcriptional repressor E4-binding protein 4 (E4BP4) regulates metabolic hormone fibroblast growth factor 21 (FGF21) during circadian cycles and feeding.Complement alternative pathway activation in human nonalcoholic steatohepatitis.Relationships of circulating sex hormone-binding globulin with metabolic traits in humans.Nonalcoholic fatty liver disease and aging: epidemiology to management.Lipid-induced insulin resistance: unravelling the mechanism.Regular exercise is associated with a reduction in the risk of NAFLD and decreased liver enzymes in individuals with NAFLD independent of obesity in Korean adults.Extracts from Salvia-Nelumbinis naturalis alleviate hepatosteatosis via improving hepatic insulin sensitivity.Common genetic variations in CLOCK transcription factor are associated with nonalcoholic fatty liver diseaseSerum amylase levels are decreased in Chinese non-alcoholic fatty liver disease patientsThe association between nonalcoholic fatty pancreas disease and diabetesHepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2Altered fatty acid metabolism-related gene expression in liver from morbidly obese women with non-alcoholic fatty liver disease.Are women with polycystic ovarian syndrome at a high risk of non-alcoholic Fatty liver disease; a meta-analysisEffect of aerobic exercise training on non-alcoholic fatty liver disease induced by a high fat diet in C57BL/6 mice.The metabolically benign and malignant fatty liver.Association between markers of fatty liver disease and impaired glucose regulation in men and women from the general population: the KORA-F4-study.Genetics in endocrinology: genetic forms of severe insulin resistance: what endocrinologists should know.Ezetimibe: its novel effects on the prevention and the treatment of cholesterol gallstones and nonalcoholic Fatty liver diseaseIntravenous Mycobacterium Bovis Bacillus Calmette-Guérin Ameliorates Nonalcoholic Fatty Liver Disease in Obese, Diabetic ob/ob Mice.Liver in the analysis of body composition by dual-energy X-ray absorptiometry.Depressive Symptoms Clusters and Insulin Resistance: Race/Ethnicity as a Moderator in 2005-2010 NHANES Data.
P2860
Q26827169-CA6AA6B1-C4BF-4BE1-8111-3568DB36733CQ26853645-ACD77301-D66E-4AF0-9755-3AF367FF9004Q26861308-CBEEB186-1399-4F11-A2A0-ACBBE61FC263Q27324243-20CD6D5F-CFD4-49E0-A85A-CB0DB835BB72Q28074269-812CDD05-FBBA-4259-9E26-80B02EA01D30Q28729002-2376EBD7-DFA6-4284-9DF2-12C02F2AC994Q30934313-3B1DFBB4-B5F4-43E3-8981-B18B9B9683F6Q33309957-9017F22B-21A7-422D-95A5-A07F711987CAQ33718945-4BBC80A6-8E1F-4268-98C2-F7C1E540B4C9Q33736297-54E94F6C-4B03-4224-A77D-634CD79CF809Q33769301-33A3A171-4C56-4841-B1C1-E87AAE97C3AFQ33804734-2E833644-D069-45AD-B512-C43ABCB316E5Q33851125-49DEFA3C-A745-48EA-B5F9-50563D76DD0EQ33883038-80764333-C8C7-47E4-A8C4-B79266054035Q33886918-F67626D6-9BBA-4871-8190-DC11881E9A52Q33886930-06CC6112-961E-4F02-B8B1-5CD9B9CBB04CQ33890230-983B157D-67B8-4FDB-9DC8-245F27D64407Q34040931-593F00F0-B8C3-465F-9FDB-CA5C29916CF9Q34168532-A0FF7704-591A-4B18-8022-2D186392811DQ34299026-90B1ECC6-E242-4341-9ADD-BAFB68C5B9FCQ34317685-F757E33D-B5C4-423F-9E06-864F7C5D9CCFQ34355301-61A45A85-0BAE-480B-AEA7-48AB160A74B1Q34366861-3D88DF8D-9751-4B93-8FFE-CF8746525B23Q34370958-4599174B-D89C-4FC7-9841-E7AEBA95F5ACQ34460342-41664B7C-D113-42C7-B175-CDD03302CCD3Q34571695-D44CFEAC-73D7-4C10-A602-535CD2B7471EQ34604846-476C55F6-B1BF-48FC-A5B9-D3991205E695Q34709831-AB0EA358-AA50-43E8-8A6A-F10C7043CFF2Q34720662-5B46A18E-0D7E-442D-BE27-C57B467E8B2AQ34804981-37AC147C-687C-4FDB-8C5B-2F572C832C3CQ34834198-7B3B54E9-B00C-4905-A8A1-FA7D7B0EF355Q34864638-C4A35646-D24E-40CF-81A9-630356B88ADBQ35064804-41053BBF-AEFE-4568-92C5-E34BE1A65481Q35123495-B7EA6157-E698-415E-951F-35ED60623413Q35150883-593D3F90-58EC-423D-A46B-B57E01EF4ADDQ35178218-6F54376C-3E60-4CC5-8565-F239AD0FEBB6Q35550630-215F9075-C8D6-4314-B79B-85E95E58A356Q35651595-48C56B6F-653F-47E2-8F9D-FE0907836743Q35676766-ABAE4B7B-DFB2-4AF3-88BF-D83E5D750C0CQ35759379-663B0118-C8CF-4F12-B67B-282BE2B6E2A4
P2860
Review: The role of insulin resistance in nonalcoholic fatty liver disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Review: The role of insulin resistance in nonalcoholic fatty liver disease.
@ast
Review: The role of insulin resistance in nonalcoholic fatty liver disease.
@en
type
label
Review: The role of insulin resistance in nonalcoholic fatty liver disease.
@ast
Review: The role of insulin resistance in nonalcoholic fatty liver disease.
@en
prefLabel
Review: The role of insulin resistance in nonalcoholic fatty liver disease.
@ast
Review: The role of insulin resistance in nonalcoholic fatty liver disease.
@en
P356
P1476
Review: The role of insulin resistance in nonalcoholic fatty liver disease.
@en
P2093
Kristina M Utzschneider
P304
P356
10.1210/JC.2006-0587
P407
P577
2006-09-12T00:00:00Z